BFB Health Limited released its Monthly Return for Equity Issuer for the period ended 30 September 2026, confirming that no changes occurred in its share capital structure during the month.
• Authorised share capital remained at 100.00 billion ordinary shares with a par value of HKD 0.01 each, equivalent to HKD 1.00 billion. • Issued share capital was unchanged at 1.25 billion ordinary shares; the company held no treasury shares. • The public float continued to comply with Hong Kong Main Board Rule 13.32B, maintaining at least the 25% minimum threshold.
Equity-linked instruments: • Share Option Scheme (adopted 30 June 2021) showed 58.40 million outstanding options, all unexercised during September. No new shares were issued and no treasury shares were transferred. A further 3.21 million shares remain available for future grants under the scheme. • The company has no outstanding warrants, convertible securities, or other agreements that could dilute equity.
Management affirmed that all regulatory requirements were met and no transactions required additional disclosure beyond those included in the return.
Comments